Oncolytics Biotech, Inc. (ONCY) is “One to Watch”
Oncolytics Biotech, Inc. (TSX: ONC NASDAQ: ONCY) engages in the discovery and development of pharmaceutical products for the treatment of a wide variety of human cancers. Founded in 1998 in Alberta, Canada, the company was initially formed to research the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, a common characteristic present in the family of genetic cell defects leading to cancer. Reovirus, or Respiratory Enteric Orphan virus, is generally believed to inhabit the respiratory and bowel systems in humans, and can be found naturally in sewage and water supplies. One…